Boston Scientific sees Q1 revenue flat to up slightly as coronavirus delays elective proceduresMarket Watch • 04/02/20
Boston Scientific withdraws financial guidance given business disruptions related to COVID-19 pandemicMarket Watch • 03/30/20
Lessons From 2008 Crisis: Could Boston Scientific Stock Underperform Post Coronavirus?Forbes • 03/12/20
How Does Boston Scientific Get To $12 Billion Sales In 2020: Rhythm & Neuro Or Cardiovascular?Forbes • 03/09/20
Boston Scientific (BSX) Down 12.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/06/20
Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/05/20
Boston Scientific Rebounds From Q4 Sales Miss, Earns Relative Strength Rating UpgradeInvestors Business Daily • 01/30/20